TCG Crossover GP II, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Dianthus Therapeutics, Inc. Common Stock, par value $0.001 per share (DNTH)

Filing Manager
TCG Crossover GP II, LLC
Reporting Manager
TCG Crossover GP II, LLC
Security
Dianthus Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
DNTH
Shares outstanding
31,949,447 shares
Disclosed Ownership
1,501,624 shares
Ownership
4.7%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:34:05 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TCG Crossover GP II, LLC 4.7% 1,501,624 0 1,501,624 /s/ Craig Skaling Authorized Signatory
TCG Crossover Fund II, L.P. 4.7% 1,501,624 0 1,501,624 /s/ Craig Skaling Authorized Signatory
Chen Yu 4.7% 1,501,624 0 1,501,624 /s/ Craig Skaling By POA as Attorney-in-Fact